Sub-Saharan Africa region is a very large and very populated region composed mainly of French speaking countries, English speaking countries and Portuguese speaking countries. MCT covers more than 20 countries through our own staff (we do NOT subcontract): Senegal, Togo, Benin, Mali, Burkina Faso, Ivory Coast, Gabon, Cameroon, DRC, Ghana, Gambia, Sierra Leone, Liberia, Nigeria, Kenya, Uganda, Tanzania, Zambia, South Africa, Mozambique, Rwanda, Malawi, Ethiopia and Zimbabwe.

The best therapeutic areas are: infectious disease & vaccine, hematology and neglected tropical disease. However, given the on-going strong demographic and economic growths, Experts all predict that the number of clinical trials will significantly increase in the next coming years in other indications too: Cardiology, Oncology, Respiratory, Diabetes…

Senegal : Population: 15 million /Other Data

Togo : Population: 9 million /Other Data

Benin : Population: 12 million / Other Data

Mali : Population: 20 million /Other Data

Burkina Faso : Population: 22 million / Other Data

Ivory Coast : Population: 27million /Other Data

Gabon : Population: 2 million /Other Data

Cameroon : Population: 27 million /Other Data

DRC : Population: 92 million /Other Data

Ghana : Population: 32 million /Other Data

Gambia : Population: 2 million /Other Data

Sierra Leone : Population: 9 million /Other Data

Liberia : Population: 5 million /Other Data

Nigeria : Population: 212 million /Other Data

Kenya : Population: 55 million /Other Data

Uganda : Population: 43 million /Other Data

Tanzania : Population: 62 million /Other Data

Zambia : Population: 18 million /Other Data

South-Africa : Population: 60 million /Other Data

Mozambique : Population: 30 million /Other Data

Rwanda : Population: 13 million /Other Data

Malawi : Population: 19 million /Other Data

Ethiopia : Population: 117 million /Other Data

Zimbabwe : Population: 15 million /Other Data

MCT coverage: MCT is the only CRO that can cover French, English and Portuguese speaking parts. We have local staff in 13 countries (Senegal, Mali, Benin, Sierra Leone, Gambia, Nigeria, Ghana, Kenya, Uganda, South Africa, Zimbabwe, Mozambique and Malawi): this is a unique strategic advantage of MCT, allowing better efficiency in managing your clinical trials: less time spent in travels, better site management, better knowledge of the field (regulatory process, best sites, local vendors, local health care system organization), and so on.

In Sub-Saharan Africa, we continue implementing MCT cornerstone policy since its start: using local staff, to ensure local expertise in each country.